https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-11-04 / Expert Opin Biol Ther 2024 Nov;24(11):1245-1259
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-11-04 / Expert Opin Biol Ther 2024 Nov;24(11):1245-12592024-11-04 00:00:002024-11-04 00:00:00The future of cellular therapy for the treatment of renal cell carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-10-09 / Oncoimmunology 2024;13(1):2412876
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-10-09 / Oncoimmunology 2024;13(1):24128762024-10-09 00:00:002024-10-09 00:00:00Trial watch: anticancer vaccination with dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-07-01 / J Clin Oncol 2024 Sep;42(26):3083-3093
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-07-01 / J Clin Oncol 2024 Sep;42(26):3083-30932024-07-01 00:00:002024-07-01 00:00:00Dendritic Cell-Based Immunotherapy in Patients With Resected Pancreatic Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-05-28 / Ann Transl Med 2024 Aug;12(4):77
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-05-28 / Ann Transl Med 2024 Aug;12(4):772024-05-28 00:00:002024-05-28 00:00:00Dendritic cell vaccination combined with irreversible electroporation for treating pancreatic cancer-a narrative review
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-04-21 / Expert Opin Biol Ther 2024 Apr;24(4):269-284
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-04-21 / Expert Opin Biol Ther 2024 Apr;24(4):269-2842024-04-21 00:00:002024-04-21 00:00:00The future of cancer vaccines against colorectal cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-04-09 / Cell Rep Med 2024 Apr;:101516
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-04-09 / Cell Rep Med 2024 Apr;:1015162024-04-09 00:00:002024-04-09 00:00:00Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-04-09 / Med Oncol 2024 Apr;41(5):112
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-04-09 / Med Oncol 2024 Apr;41(5):1122024-04-09 00:00:002024-04-09 00:00:00Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-03-28 / Biomedicines 2024 Mar;12(4)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-03-28 / Biomedicines 2024 Mar;12(4)2024-03-28 00:00:002024-04-30 08:35:31Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-03-21 / Front Immunol 2024;15:1375433
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-03-21 / Front Immunol 2024;15:13754332024-03-21 00:00:002024-03-21 00:00:00New hopes for the breast cancer treatment: perspectives on the oncolytic virus therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-03-16 / Inflammation 2024 Mar;
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-03-16 / Inflammation 2024 Mar;2024-03-16 00:00:002024-03-16 00:00:00An Advanced Intrahepatic Cholangiocarcinoma Patient Benefits from Personalized Immunotherapy
